Value-Based Agreements On The Cards For UniQure/CSL’s $3.5m Hemophilia B Gene Therapy

On Top Of Up To 30% Discounts

 
• By Ayisha Sharma
  
Animated dollar bills and coins
Value-Based Agreements Help Parse Out Risks Associated With Expensive Therapies • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip